自由细胞DNA作为急性心肌梗塞的潜在生物标志物:系统性审查和元分析
Elinor Tan1, Daniel Liu2, Luke Perry2
1Department of Intensive Care Unit, The Royal Melbourne Hospital, Melbourne, Australia.
在急性心肌梗塞 (AMI) 患者中,无细胞脱氧核糖核酸 (cfDNA) 的水平升高. 这一元分析表明cfDNA是心肌损伤的可靠生物标志物,具有很高的诊断准确性.
科学领域:
- 生物化学 生物化学
- 心脏病学 心脏病学
- 分子诊断学 分子诊断学
背景情况:
- 组织亡释放无细胞脱氧核糖核酸 (cfDNA),增加了血的度.
- cfDNA清除独立于功能.
研究的目的:
- 系统地审查和元分析cfDNA在急性心肌梗塞 (AMI) 中的诊断作用.
主要方法:
- 一个系统的审查和对17项涉及1804名患者的研究的元分析.
- 诊断准确性是通过聚合灵敏度,特异性和曲线下的面积 (AUC) 来评估的.
- 使用QUADAS-2工具评估了方法质量.
主要成果:
- 与对照组相比,AMI患者的循环cfDNA度明显高于AMI患者 (SMD 3.47).
- 综合敏感度为87%,特异性为96%用于诊断AMI.
- 在研究中观察到大量的异质性,可能是由于cfDNA量化方法的变化.
结论:
- 血cfDNA是心肌损伤的可靠生物标志物.
- 限制包括方法的异质性,影响研究结果的概括性.
- 需要进一步的研究来标准化cfDNA量化用于临床应用.
更多相关视频
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
